The impact of personalised therapies on respiratory medicine
Stratified approaches to treating disease are very attractive, as efficacy is maximised by identifying responders using a companion diagnostic or by careful phenotyping. This approach will spare non-responders form potential side-effects. This has been pioneered in oncology where single genes or gen...
Autor principal: | J. Stuart Elborn |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
European Respiratory Society
2013-03-01
|
Col·lecció: | European Respiratory Review |
Matèries: | |
Accés en línia: | http://err.ersjournals.com/content/22/127/72.full.pdf+html |
Ítems similars
-
Prospects for the Management of Sepsis in an Era of Personalised Medicine
per: Jonathan Cohen
Publicat: (2019-03-01) -
Multiple Myeloma: Personalised Medicine Based on Pathogenesis
per: Wen-Chi Yang, et al.
Publicat: (2018-03-01) -
The genetics of gout: towards personalised medicine?
per: Nicola Dalbeth, et al.
Publicat: (2017-05-01) -
The Role of Endoscopic Ultrasound in Pancreatic Cancer Staging in the Era of Neoadjuvant Therapy and Personalised Medicine
per: Miguel Bispo, et al.
Publicat: (2020-09-01) -
Recommendations for robust and reproducible preclinical research in personalised medicine
per: Vibeke Fosse, et al.
Publicat: (2023-01-01)